Exelixis Inc. (NASDAQ: EXEL) Price Target Increased at Stifel Nicolaus

Exelixis Inc. (NASDAQ: EXEL) had its price target boosted by equities researchers at Stifel Nicolaus from $12.00 to $15.00. The company currently has a rating of Buy on the stock. A number of other analysts have spoken on the company recently, and Exelixis Inc. has earned a consensus one-year price target of $10.67, lower than the opening price of $13.13, a difference of 8.00 percent. Exelixis Inc. stock has a 52-week high of $13.49.

U.S. stocks finished higher Thursday, near their intra-day highs.

The Dow Jones Industrial Average DJIA, +0.99% closed up 177.71 points, or 1%, at 18,212.48, led by a 3.4% surge in shares of Apple Inc. AAPL, +3.40%

All 30 of the Dow components finished in the green.

The S&P 500 index SPX, +1.01% wrapped up 21.49 points, or 1%, to 2,147.26, and all the large-cap gauge’s sectors ended higher, topped by a 1.7% rise in the tech sector and a 1.1% gain in health-care shares

Typically, after analysts publish an “initiating coverage” report on a stock, they will subsequently issue periodic updates.

Shares of Exelixis Inc. (NASDAQ: EXEL) opened at $13.13 yesterday and traded in a range between, $12.93 and $13.49, and last traded at $13.34, which represents a change of $ 0.33 over the previous closing price.

Exelixis Inc. (NASDAQ: EXEL) currently has a market cap of 3.07B

The stocks average daily volume is 5,946,410 shares out of a total float 212,111,000 and some 5,685,969 shares crossed the trading desk yesterday, 48 percent lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these retain substantial teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

With that in mind Exelixis Inc. (NASDAQ: EXEL) now has a 50-day MA is $11.05 and 200-day MA is $7.11, and it has traded in a 52-week range between $3.55 – 13.49 and today’s last price is -1.11 percent off the 52 week high of $13.49.

Earnings growth is an important factor toresearch when investing in stocks and investors look for companies that have grown their earnings at least 25% or more for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of The Woodbridge Citizen. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.